- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 19V: 4-[5-(4-tert-butylpiperazin-1-yl)pyridin-2-yl]-N-[(1R,2S,3S,5S,7s)-5-carbamoyltricyclo[3.3.1.1~3,7~]dec-2-yl]-3,4-dihydroquinoxaline-1(2H)-carboxamide(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 28 residues within 4Å:- Chain A: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217
- Ligands: 19V.1
27 PLIP interactions:27 interactions with chain A- Hydrophobic interactions: A:L.209
- Hydrogen bonds: A:G.35, A:S.37, A:S.37, A:K.38, A:I.40, A:R.60, A:S.61, A:T.86, A:M.87, A:N.113, A:N.113, A:I.115, A:Y.141, A:K.181, A:I.212, A:T.214, A:T.214, A:T.216, A:T.216
- Water bridges: A:K.38, A:G.41, A:R.60, A:S.61, A:S.61, A:T.214
- Salt bridges: A:R.60
NDP.4: 29 residues within 4Å:- Chain B: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, Y.141, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217
- Ligands: 19V.3
34 PLIP interactions:34 interactions with chain B- Hydrophobic interactions: B:L.209
- Hydrogen bonds: B:G.35, B:S.37, B:S.37, B:K.38, B:I.40, B:R.60, B:R.60, B:S.61, B:T.86, B:T.86, B:M.87, B:N.113, B:N.113, B:I.115, B:Y.141, B:Y.177, B:K.181, B:I.212, B:T.214, B:T.214, B:T.214, B:T.216, B:T.216
- Water bridges: B:S.37, B:K.38, B:K.38, B:G.39, B:G.41, B:S.61, B:T.116, B:T.116
- Salt bridges: B:K.38, B:R.60
NDP.6: 29 residues within 4Å:- Chain C: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, E.88, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217
- Ligands: 19V.5
24 PLIP interactions:24 interactions with chain C- Hydrophobic interactions: C:L.209
- Hydrogen bonds: C:S.37, C:S.37, C:K.38, C:K.38, C:I.40, C:R.60, C:S.61, C:T.86, C:M.87, C:E.88, C:N.113, C:N.113, C:I.115, C:K.181, C:I.212, C:T.214, C:T.214, C:T.216, C:T.216
- Water bridges: C:G.41, C:T.214
- Salt bridges: C:K.38, C:R.60
NDP.8: 28 residues within 4Å:- Chain D: G.35, A.36, S.37, K.38, G.39, I.40, A.59, R.60, S.61, G.85, T.86, M.87, N.113, H.114, I.115, V.162, S.163, S.164, Y.177, K.181, L.209, G.210, L.211, I.212, T.214, T.216, A.217
- Ligands: 19V.7
28 PLIP interactions:28 interactions with chain D- Hydrophobic interactions: D:L.209
- Hydrogen bonds: D:G.35, D:S.37, D:S.37, D:K.38, D:I.40, D:R.60, D:S.61, D:T.86, D:T.86, D:M.87, D:N.113, D:N.113, D:I.115, D:Y.177, D:K.181, D:I.212, D:I.212, D:T.214, D:T.214, D:T.216
- Water bridges: D:G.41, D:T.116, D:T.116, D:T.116, D:T.216
- Salt bridges: D:K.38, D:R.60
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Venier, O. et al., Discovery of SAR184841, a potent and long-lasting inhibitor of 11beta-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D. Bioorg.Med.Chem.Lett. (2013)
- Release Date
- 2013-05-08
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.19 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 19V: 4-[5-(4-tert-butylpiperazin-1-yl)pyridin-2-yl]-N-[(1R,2S,3S,5S,7s)-5-carbamoyltricyclo[3.3.1.1~3,7~]dec-2-yl]-3,4-dihydroquinoxaline-1(2H)-carboxamide(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Venier, O. et al., Discovery of SAR184841, a potent and long-lasting inhibitor of 11beta-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D. Bioorg.Med.Chem.Lett. (2013)
- Release Date
- 2013-05-08
- Peptides
- Corticosteroid 11-beta-dehydrogenase isozyme 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D